TR199800270T1 - Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi. - Google Patents

Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi.

Info

Publication number
TR199800270T1
TR199800270T1 TR1998/00270T TR9800270T TR199800270T1 TR 199800270 T1 TR199800270 T1 TR 199800270T1 TR 1998/00270 T TR1998/00270 T TR 1998/00270T TR 9800270 T TR9800270 T TR 9800270T TR 199800270 T1 TR199800270 T1 TR 199800270T1
Authority
TR
Turkey
Prior art keywords
fluconazole
progression
preventing
cancer diseases
cancer
Prior art date
Application number
TR1998/00270T
Other languages
English (en)
Inventor
Berger Camden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199800270T1 publication Critical patent/TR199800270T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Memelilerde kanserlerin ya da tümörlerin iyilestirilmesi için bir farmasötik bilesim anlatilmistir, bu bilesim,
TR1998/00270T 1995-08-04 1996-07-30 Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi. TR199800270T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections

Publications (1)

Publication Number Publication Date
TR199800270T1 true TR199800270T1 (tr) 1998-05-21

Family

ID=26669622

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1998/01739T TR199801739T2 (tr) 1995-08-04 1996-07-30 Viral enfeksiyonlarin tedavisinde flukonazol kullanimi.
TR1998/00270T TR199800270T1 (tr) 1995-08-04 1996-07-30 Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR1998/01739T TR199801739T2 (tr) 1995-08-04 1996-07-30 Viral enfeksiyonlarin tedavisinde flukonazol kullanimi.

Country Status (18)

Country Link
EP (1) EP0841921A2 (tr)
JP (1) JPH11510187A (tr)
KR (1) KR19990036138A (tr)
CN (1) CN1195288A (tr)
AR (1) AR003175A1 (tr)
AU (1) AU711966B2 (tr)
BR (1) BR9609966A (tr)
CA (1) CA2229024A1 (tr)
CZ (1) CZ33798A3 (tr)
HU (1) HUP9903420A3 (tr)
IL (1) IL123095A0 (tr)
MX (1) MX9800998A (tr)
NO (1) NO980473L (tr)
NZ (2) NZ315184A (tr)
PL (1) PL324904A1 (tr)
SK (1) SK14198A3 (tr)
TR (2) TR199801739T2 (tr)
WO (1) WO1997005873A2 (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (fr) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto Unite motrice susceptible d'etre accouplee a une enceinte roulante et vehicule resultant
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1616572B1 (en) * 1998-11-09 2010-09-01 Biogen Idec Inc. Chimeric anti-CD20 antibody, rituxan, for use in the treatment of chronic lymphocytic leukemia
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
NO980473D0 (no) 1998-02-03
PL324904A1 (en) 1998-06-22
SK14198A3 (en) 1999-03-12
BR9609966A (pt) 1999-02-02
CZ33798A3 (cs) 1998-06-17
NZ315184A (en) 2000-05-26
HUP9903420A3 (en) 2001-12-28
NO980473L (no) 1998-04-03
NZ503921A (en) 2002-03-01
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
TR199801739T2 (tr) 1998-12-21
CN1195288A (zh) 1998-10-07
JPH11510187A (ja) 1999-09-07
AU6683396A (en) 1997-03-05
EP0841921A2 (en) 1998-05-20
IL123095A0 (en) 1998-09-24
MX9800998A (es) 1998-04-30
KR19990036138A (ko) 1999-05-25
WO1997005873A3 (en) 1997-03-27
HUP9903420A2 (hu) 2000-03-28
AR003175A1 (es) 1998-07-08
WO1997005873A2 (en) 1997-02-20

Similar Documents

Publication Publication Date Title
TR199800270T1 (tr) Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi.
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
MX9305934A (es) Nuevo modificador de resistencia a drogas multiples.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
CY1105144T1 (el) Χρηση μιας ουσιας που συνδεεται στον πepιφepειακο υποδοχεα των βενζοδιαζεπινων στη θepαπεια του δepματικου στρες
TR200102287T2 (tr) Bis-1,2,4-triazollerin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanımı
ITMI990375A1 (it) Trattamento del cancro co epotiloni
FI965269A0 (fi) Menetelmä syövän etäispesäkkeen ehkäisemiseksi modifioidun citrus pektiinin avulla
TR200001544T2 (tr) Yeni bileşikler.
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
TR199802423T2 (tr) Konsantre antikor terkibi.
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
ATE404667T1 (de) Chromatin-regulatorgene
ATE231872T1 (de) Thiazolopyrimidinderivate
BR9608488A (pt) Uso de derivados da vitamina d4 no tratamento de câncer
SE9802937D0 (sv) Novel compounds
TR200103786T2 (tr) Güğüs kanserinin tehisi ve imünoterapisi için bileşikler ve bunların kullanımı
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
CY1106525T1 (el) ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΜΕ hCG ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΜΕΤΑΣΤΑΤΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΜΑΣΤΟΥ
DE60015957D1 (de) Selen enthaltendes vorstufearzneimittel für krebstherapie
BR0008305A (pt) Utilização de uma proteìna ompa de enterobactéria, ou de um de seus fragmentos e composição farmacêutica
ATE218881T1 (de) Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin
NO20005548L (no) Mykobakterieinhibitorer
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
PT1708693E (pt) Composições farmacêuticas contendo complexos de platina com xantatos secundários e suas utilizações terapêuticas